SWElife Overview

  • Investor Type

  • Accelerator/​Incubator

  • Investments

  • 16

  • Portfolio

  • 13

  • Exits

  • 1

Exits

SWElife General Information

Contact Information

Website
swelife.se
Primary Investor Type
Accelerator/Incubator
Primary Office
  • Lund university Forskning, Samverkan och Innovation
  • Swelife Box 117, SE-221 00 Lund, Sweden
  • 221 00 Lund
  • Sweden
+46 070-519 00 00

SWElife Investments (16)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
BioReperia 06-Apr-2021 Grant 00000 Other Pharmaceuticals and Biotechnology Generating Revenue
0000000 01-Oct-2020 00000 00.000 Drug Discovery Clinical Trials - Phase 2
00000000 000 21-Apr-2020 00000 00000 Drug Delivery Product Development
00000 0000000 11-Dec-2019 00000 00.000 Drug Discovery Clinical Trials - Phase 2
0000000 01-Dec-2019 00000 00000 Drug Delivery Clinical Trials - Phase 1
00000000 000000000 18-Jun-2019 00000 00000 Drug Discovery Pre-Clinical Trials
0000000000 22-May-2019 00000 00000 00000 Other Pharmaceuticals and Biotechnology Generating Revenue
0000 00000000000 15-Nov-2018 00000 00000 Diagnostic Equipment Generating Revenue
Neoss 31-May-2018 Grant 00000 Therapeutic Devices Generating Revenue
Glactone Pharma 24-May-2018 Grant Pharmaceuticals Pre-Clinical Trials
You’re viewing 10 of 16 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SWElife Exits (1)

Company Name Exit Date Exit Type Exit Size
00000 22-Dec-2020 0000000000
To view SWElife’s complete exits history, request access »

SWElife Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial